医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19

摘要Background and aim:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),the virus responsible for the current pandemic,can have multi-organ impact.Recent studies show that liver injury could be a manifestation of the disease,and that liver disease could also be related to a worse prognosis.Our aim was to compare the characteristics of patients with severe coronavirus disease 2019 (COVID-19)due to SARS-CoV-2 who required intubation versus stable hospitalized patients to identify the early biochemical predictive factors of a severe course of COVID-19 and subsequent requirement for intuba-tion,specifically in Mexican.Methods:This was an observational case-control study nested in a cohort study.Complete medical re-cords of patients admitted for confirmed COVID-19 at a tertiary level center in Mexico City were reviewed.Clinical and biochemical data were collected,and the characteristics of patients who required invasive mechanical ventilation (IMV) (cases) were compared with stable hospitalized patients without ventilation (controls).Results:We evaluated 166 patients with COVID-19 due to SARS-CoV-2 infection;114 (68.7%) were men,the mean age was 50.6 ± 13.3 years,and 27 (16.3%) required IMV.The comparative analysis between cases and controls showed (respectively) significantly lower blood oxygen saturation (SpO2)(73.5 ± 12.0% vs.83.0 ± 6.8%,P < 0.0001) and elevated alanine aminotransferase (ALT) (128 (14-1123) IU/L vs.33 (8-453) IU/L,P =0.003),aspartate aminotransferase (AST) (214 (171247) vs.44 (12-498) IU/L,P =0.001),lactic dehydrogenase (LDH) (764.6 ± 401.9 IU/L vs.461.0 ± 185.6 IU/L,P =0.001),and D-dimer(3463 (524-34,227) ng/mL vs.829 (15241,923) ng/mL,P 0.003) concentrations.Patients in the cases group were older (58.6 ± 12.7 years vs.49.1 ± 12.8 years,P=0.001).Multivariate analysis showed that important factors at admission predicting the requirement for IMV during hospitalization for COVID-19 were AST ≥250 IU/L (odds ratio (OR) 64.8,95% confidence interval (Cl) 7.5-560.3,P < 0.0001) and D-dimer ≥ 3500 ng/mL (OR =4.1,95% CI 1.2-13.7,P=0.02).Conclusions:Our study confirms the importance of monitoring liver enzymes in hospitalized patients with COVID-19;seriously ill patients have significantly elevated AST and D-dimer concentrations,which have prognostic implications in the SARS-CoV-2 disease course.

更多
广告
作者 Fátima Higuera-de la Tijera [1] Alffedo Servín-Caama(n)o [2] Daniel Reyes-Herrera [2] Argelia Flores-López [2] Enrique J.A.Robiou-Vivero [2] Felipe Martínez-Rivera [2] Victor Galindo-Hernández [2] Oscar Chapa-Azuela [3] Alfonso Chávez-Morales [4] Victor H.Rosales-Salyano [2] 学术成果认领
作者单位 Multidisciplinary Team for the Attention and Care of Patients with COVID-19,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico;Gastroenterology and Hepatology Department,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico [1] Multidisciplinary Team for the Attention and Care of Patients with COVID-19,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico;Internal Medicine Department,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico [2] Multidisciplinary Team for the Attention and Care of Patients with COVID-19,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico;Hepatobiliary and Pancreatology Clinic,Surgery Department,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico [3] Multidisciplinary Team for the Attention and Care of Patients with COVID-19,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico;Intensive Care Unit,Hospital General de México Dr.Eduardo Liceaga,Mexico City,Mexico [4]
栏目名称
发布时间 2021-10-09(万方平台首次上网日期,不代表论文的发表时间)
  • 浏览5
  • 下载1
肝脏研究(英文)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷